Short Interest in Medicure Inc. (OTCMKTS:MCUJF) Grows By ∞

Medicure Inc. (OTCMKTS:MCUJFGet Free Report) was the recipient of a significant growth in short interest in the month of August. As of August 31st, there was short interest totaling 5,532 shares, a growth of ∞ from the August 15th total of 0 shares. Based on an average daily trading volume, of 26,278 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.1% of the company’s shares are short sold.

Medicure Stock Down 3.8%

Shares of MCUJF opened at $1.79 on Tuesday. Medicure has a fifty-two week low of $0.67 and a fifty-two week high of $1.89. The company’s fifty day moving average is $1.08 and its two-hundred day moving average is $0.90. The firm has a market cap of $18.69 million, a PE ratio of -3.51 and a beta of 1.15. The company has a quick ratio of 0.64, a current ratio of 0.97 and a debt-to-equity ratio of 0.02.

Medicure (OTCMKTS:MCUJFGet Free Report) last posted its earnings results on Friday, August 14th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.05). Medicure had a negative return on equity of 54.55% and a negative net margin of 23.14%.The business had revenue of $5.36 million for the quarter, compared to analyst estimates of $2.45 million.

About Medicure

(Get Free Report)

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.

Featured Articles

Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.